Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021
Talis Biomedical Corporation (TLIS) announced it will release its third-quarter financial results on November 15, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Talis Biomedical Corporation (TLIS) announced it will release its third-quarter financial results on November 15, 2021, after market close. A conference call to discuss the results will follow at 1:30 PM PT (4:30 PM ET). Interested parties can join via phone or access a live webcast through the company's investor website. Talis is focused on developing innovative molecular diagnostic tests for infectious diseases, aiming to provide rapid, low-cost testing at the point of care with its Talis One device.
Positive
- Talis is developing the Talis One, a rapid molecular diagnostic instrument designed for point-of-care testing.
- Focus on innovative molecular diagnostic tests for infectious diseases indicates potential market growth.
Negative
- None.
Details
News Market Reaction – TLIS
The recorded move for TLIS in the trading session of this news was -3.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the third quarter after market close on Monday, November 15, 2021. Talis will host a conference call, beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss financial and operational results.
Interested parties may access the live call via telephone by dialing 833-715-1329 for participants in the U.S. or Canada and 430-775-1933 for international callers, using conference ID 3618139. A live and archived webcast of the event can be accessed via the News & Events page of the investor section of Talis Biomedical’s website at www.talis.bio.
About Talis Biomedical
Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost, and rapid molecular testing for infectious diseases at the point of care. The company is developing the Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic instrument. For more information, visit talisbio.com.
Contact
Media & Investors
Emily Faucette
ir@talisbio.com
415-595-9407
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.